title: Angiotensin converting enzyme inhibitors remain the first treatment of choice.
authors.affiliation: Division of Cardiology, Department of Internal Medicine, Heart Center, Gachon University Gil Medical Center, Incheon, Korea.|Gachon Cardiovascular Research Institute, Incheon, Korea.
authors.forename: Pyung Chun
authors.initials: PC
authors.lastname: Oh
authors.affiliation: Cardiovascular Medicine, Hokko Memorial Clinic, Sapporo, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Sakuma
authors.affiliation: Department of Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
authors.forename: Toshio
authors.initials: T
authors.lastname: Hayashi
authors.affiliation: Division of Cardiology, Department of Internal Medicine, Heart Center, Gachon University Gil Medical Center, Incheon, Korea.|Gachon Cardiovascular Research Institute, Incheon, Korea.
authors.forename: Kwang Kon
authors.initials: KK
authors.lastname: Koh
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors; D006801:Humans
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors